A lack of diverse representation of patients in clinical research has made it difficult to adequately assess the unique patient journey and efficacy of treatment for minority MS patients in comparison to non-Hispanic Caucasian women. According to a recent study published earlier this year in Multiple Sclerosis and Demyelinating Disorders. The African-American population in...